ImmunityBio IBRX
NASDAQ IBRX
$9.28 -0.16 (-1.69%)
At close: Oct 1, 2026 · 4:00 PM EDT

ImmunityBio (IBRX) Non-Current Deffered Revenue (2014 - 2017)

Updated

ImmunityBio (IBRX) posted Non-Current Deffered Revenue of $166,000 for Q4 2017, down 11.2% from $187,000 a year earlier.

Analysis

ImmunityBio (IBRX) Non-Current Deffered Revenue (2014 - 2017) Analysis & Trends

Since Q4 2014, ImmunityBio has reported Non-Current Deffered Revenue for 8 quarters.

  • Annual Non-Current Deffered Revenue has declined for three consecutive years, with a three-year compound annual growth rate of -31.7% (FY2014 to FY2017).
  • In prior years, ImmunityBio's Non-Current Deffered Revenue was $187,000 in FY2016 (-18.0%), $228,000 in FY2015 (-56.2%) and $521,000 in FY2014.
  • The Q4 2017 figure stands as the lowest quarterly Non-Current Deffered Revenue in data going back to Q4 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 ImmunityBio 9.94 Bn 8.70 Bn 50.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 166,000.00
Mar 31, 2017 182,000.00
Dec 31, 2016 187,000.00
Sep 30, 2016 192,000.00
Jun 30, 2016 197,000.00
Mar 31, 2016 203,000.00
Dec 31, 2015 228,000.00
Dec 31, 2014 521,000.00
API Access

ImmunityBio Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=IBRX&period=max&api_key=YOUR_API_KEY